This systematic review considers the evidence supporting the use of prophylactic dressings for the prevention of pressure ulcer. Electronic database searches were conducted on 25 July 2013. The searches found 3026 titles and after removal of duplicate records 2819 titles were scanned against the inclusion and exclusion criteria. Of these, 2777 were excluded based on their title and abstract primarily because they discussed pressure ulcer healing, the prevention and treatment of other chronic and acute wounds or where the intervention was not a prophylactic dressing (e.g. underpads, heel protectors and cushions). Finally, the full text of 42 papers were retrieved. When these 42 papers were reviewed, 21 were excluded and 21 were included in the review. The single high-quality randomised controlled trial (RCT) and the growing number of cohort, weak RCT and case series all suggest that the introduction of a dressing as part of pressure ulcer prevention may help reduce pressure ulcer incidence associated with medical devices especially in immobile intensive care unit patients. There is no firm clinical evidence at this time to suggest that one dressing type is more effective than other dressings.
Description of the health problem
Management of both the duration and magnitude of the mechanical loads applied to skin and soft tissues has long been seen as the essential element of pressure ulcer prevention and management (1) . These mechanical loads, for example, direct pressure, shear or friction, have been typically considered to be best managed either through manual repositioning of patients or through the use of a variety of pressure-redistributing support surfaces. Apart from reducing friction and at times shear, alternative approaches to achieving modification of applied mechanical loads were not considered within the 2009 International Pressure Ulcer guidelines (1) .
Over the last 20 years there has been sporadic interest in the role that prophylactic dressings may play in both redistributing pressure and protecting the skin from the effects of shear and friction (2) . There has also been recent discussion that microclimate control (defined as including management of temperature, humidity, moisture and skin surface pH) may
Key Messages
• systematic review of the role of prophylactic dressings in pressure ulcer prevention • three randomised controlled trials (RCTs) were identified; of these two were small and failed to describe how random allocation to treatment was achieved; the final RCT was appropriately powered with adequate description of the elements of pressure ulcer prevention that were provided in addition to the placement of a soft silicone foam dressing over the sacrum. This RCT indicated that use of the soft silicone foam dressing significantly reduced the incidence of pressure ulcers compared to similar patients who received preventive care but no dressing • all the 18 non-RCT studies reported low pressure ulcer incidence where dressings were applied to the sacrum, heels, nose and trochanter; however, these studies were methodologically weak and Hawthorne effects cannot be discounted when considering their data • there were only three methodologically weak comparisons between the effect of different dressing materials upon reductions in pressure ulcer incidence play a key role in pressure ulcer prevention (3, 4) ; given the role of advanced wound dressings in exudate management it is most probable that wound dressings will alter the local wound or skin microclimate. The purpose of this systematic review was to consider whether the introduction of prophylactic dressings for pressure ulcer prevention can lead to reductions in the occurrence of superficial (category I and II) pressure ulcers (5) .
Research questions
The questions that this systematic review considered were as follows:
1. What evidence was available to indicate that the use of dressings in pressure ulcer prevention leads to reduced pressure ulcer incidence? 2. What evidence was available to indicate that different types of prophylactic dressing may have a greater or lesser effect upon the prevention of superficial pressure ulcers?
Identification of studies and search strategy
This review was commissioned by a product manufacturer (Molnlycke Healthcare, Gothenburg, Sweden) and no review protocol was developed or made available for comment. The review process was conducted and the results were reported following the PRISMA statement (6) . The search strategy comprised the following main elements: A search of four electronic bibliographic databases (Medline, Cochrane Library, CINAHL Plus and PubMed) was performed on 25 July 2013 for studies that met the inclusion criteria. The databases were searched from inception to the date of the search but limited to publications in English. The search strategy used in CINAHL Plus is described below. S1 TX Pressure ulcer S2 TX Pressure sore S3 TX Decubitus ulcer S4 TX Bedsore S5 Pressure injury S6 S1 OR S2 OR S3 OR S4 OR S5 S7 TX Prevention S8 S6 AND S7 S9 TX Dressing S10 S8 AND S9
Bibliographies of included studies were searched for further relevant studies. References were managed using EndNote version 17 (Thomson Reuters, New York, NY). Further Internet searches were performed on 26 July 2013 using Google and entering 'wound dressing and pressure ulcer prevention (along with common alternative terms -bedsore, decubitus ulcer, pressure sore and pressure injury)' as search terms. Additional publications were provided by the funder of the review work (Molnlycke Healthcare) and all of these had also been retrieved using the search strategy.
Inclusion criteria
The inclusion criteria for the systematic review are summarised in Table 1 .
Exclusion criteria
Reports describing product news were excluded from the final review along with non-systematic reviews containing no primary data, testimonials and laboratory-based in vitro studies.
Study selection
Based on the above inclusion criteria, papers were selected for review from the titles and abstracts generated by the search strategy. This was done by a single reviewer (MC) with the other review authors independently checking the papers selected for review and the discrepancies were resolved through discussion. Retrieved papers were reviewed and selected against the inclusion criteria in the same manner.
Data extraction
Data were extracted from included studies by one reviewer (MC) using standardised data extraction forms made available by SIGN (Scottish Intercollegiate Guidelines Network) (http:// www.sign.ac.uk/methodology/checklists.html) and checked by the other review authors. Data were gathered on the basis of design, participants, methods, outcomes, baseline characteristics and results of the studies.
Critical appraisal -assessing risk of bias
Studies were assessed for internal and external validity according to the criteria suggested by SIGN based on study type. The quality of case series was assessed using the checklist provided by Moga et al. (7) with this checklist validated for all published case series with multiple subjects.
Methods for analysis and synthesis
Analysis was carried out using Review Manager (RevMan) v5 (Cochrane Collaboration). The principal summary measure was relative risk (RR) with 95% confidence intervals (CIs) using random effects model. 
Synthesis
All studies had a narrative synthesis.
Randomised controlled trials, controlled trials and cohort studies
Statistical heterogeneity was tested using the I 2 measure of inconsistency within RevMan 5 (Cochrane Collaboration) where an I 2 below 40% might indicate that statistical heterogeneity may not be important (8) . Clinical and methodological heterogeneity were explored through assessment of the study populations, methods and interventions. Funnel plots were used to ascertain the potential of publication bias.
Case series
As with other study designs included in this review clinical heterogeneity was explored through assessment of the study populations, methods and interventions.
Results

Number and type of studies included
Electronic database searches were conducted on 25 July 2013. The searches found 3026 titles and after removal of duplicate records 2819 titles were scanned against the inclusion and exclusion criteria. Of these titles, 2777 were excluded on the basis of their title and abstract primarily because they discussed pressure ulcer healing, the prevention and treatment of other chronic and acute wounds or where the intervention was not a prophylactic dressing (e.g. underpads, heel protectors and cushions). Finally, the full text of 42 papers were retrieved. When these 42 papers were reviewed, 21 were excluded and 21 were included. The flow chart of the selection process is shown in Figure 1 .
Results
Of the 21 retrieved studies, 9 had a comparator arm (9) (10) (11) (12) (13) (14) (15) (16) (17) in which no prophylactic dressing was used to augment pressure ulcer prevention and these studies are summarised in Table 2 . The study designs differed with two randomised controlled trials (RCTs) (9, 10) , five cohort studies (11) (12) (13) (14) (15) and one within-subject design where prophylactic dressings were applied to one trochanter with the other trochanter dressing free (16) . The report of the final controlled study did not specify its design (17) .
The nine studies were clinically and methodologically heterogeneous given that they recruited subjects within different care settings, and reported on the four body sites where pressure ulcers might occur that were dressed with a variety of prophylactic dressings ( Table 2 ). Statistical comparison of heterogeneity across the nine studies also indicated substantial heterogeneity (I 2 = 54%) between studies. Given this heterogeneity, no synthesis of all nine retrieved studies was undertaken. Table 3 details the quality of the nine studies that ranged from low to moderately high. Common failings included no masked assessment of outcomes, while all except Santamaria et al. (9) and Cubit et al. (15) did not report the number of patients approached to participate in the study and with baseline characteristic of the control and intervention arms unreported in two studies (10, 17) . A funnel plot ( Figure 2 ) was constructed to assess the potential for publication bias Opinion/non systematic reviews with no primary data (n=9)
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with no apparent bias towards the less precise studies having the most positive effect on outcomes, although the variability detailed in Figure 2 may simply reflect the heterogeneity of methods used in the studies.
Pressure ulcers at the nose
Three studies investigated the role of prophylactic dressings to protect the nose from contact with medical devices (nasal masks and nasotracheal tubes) (10) (11) (12) . The heterogeneity of these three studies was calculated (I 2 = 0%) and given the lack of statistical heterogeneity, the three studies were combined ( Figure 3 ). Weng (11) compared the incidence of pressure ulcers among three cohorts of patients -with no dressing, a transparent film or a hydrocolloid dressing placed between nasal face masks and the skin. The results from the groups who received the film or the hydrocolloid dressing are combined in Figure 3 (pressure ulcer incidence category I film dressing 16/30 and hydrocolloid 12/30 combined incidence 28/60). In each study retrieved within this review there was no attempt to discriminate between blanching and nonblanching erythema nor were other causes of skin changes, for example, incontinence-associated dermatitis or allergic reaction to the dressing material considered. The three studies in nasal pressure ulcer prevention reported lower pressure ulcer incidence in the cohorts where dressings were used to protect the skin from medical devices (overall RR = 0·53, 95% CI 0·39-0·64). Use of a prophylactic dressing in the care of two patients would prevent one person developing a nasal pressure ulcer caused by medical devices.
Pressure ulcers at the heels
Two studies (9,13) reported the incidence of new heel ulcers irrespective of whether the heel was covered with a prophylactic dressing or not. Santamaria et al. (9) reported the results of 440 trauma and critically ill patients admitted to a single hospital through its emergency department. The subjects were randomly allocated pressure ulcer preventive care that included or lacked the application of soft silicone foam dressings to the sacrum and heels. Other elements of preventive care included all subjects being allocated a lossair-loss bed, regular risk assessment and repositioning along with skin care. Three subjects developed heel ulcers (3/161; 1·9%) where a soft silicone dressing was applied to the heels with 12/152 (7·9%) having new heel ulcers where no dressing was applied. Forni et al. (13) recruited orthopaedic patients wearing a lower leg cast that incorporated the foot. In the first cohort (n = 86) no dressing was applied over the heel under the cast, while a later cohort (n = 72) received a polyurethane foam dressing to protect the heel. Only subsets of the study data were reported with the number of subjects Table 2 Summary characteristics of the ten studies where comparisons were made between the incidence of pressure ulcers where (a) the skin was protected with a prophylactic dressing and where no dressing was applied and (b) where the effect of different dressings upon pressure ulcer incidence was compared with category I pressure ulcers at recruitment whose pressure ulcers later deteriorated being 21 of 49 (42·9%) where no dressing was applied, while 2 of 56 (3·6%) subjects exhibited similar deterioration where the dressing was applied between the heel and the cast. The studies by Santamaria et al. (9) and Forni et al. (13) were not combined given the differences in the reported outcome measures, such as incidence of new pressure damage and deterioration of existing pressure damage.
Pressure ulcers at the sacrum
Four studies (9,12,15,17) described the incidence of sacral pressure ulcers where the skin was or was not protected with a prophylactic dressing. Figure 4 combines the four studies with a RR of 0·37 (95% CI 0·21-0·67). Three of the studies used a soft silicone foam dressing to protect the sacrum (9, 12, 15) ; the final study used a polyurethane film dressing, which was applied to the sacrum during the surgery (17) . The heterogeneity of these four studies was calculated (I 2 = 0%) and given the lack of statistical heterogeneity, the studies were combined (Figure 4) . Where a soft silicone foam dressing was applied to the sacrum in trauma and critically ill patients (9, 12) , new pressure ulcers appeared in 3 of 161 (9) and in 1 of 50 (12) cases, whereas the incidence was higher if no dressing was applied -8 of 152 (9) and 4 of 35 (12). Cubit et al. (15) compared the incidence of category I and II pressure ulcers among patients admitted to acute medical wards through a single-centre emergency department -where soft silicone dressing was used, 1 of 50 developed a sacral pressure ulcer with 6 of 68 similar patients with no dressing in place to augment prevention, developed similar wounds. Studies (9, 12, 15) were clinically homogeneous (similar patient populations receiving appropriate pressure ulcer preventive care with or without dressing use) but methodologically different [RCT (9) and cohort studies (12, 15) with allocation to the group provided dressings to protect the skin based on which room the patient was allocated (9) or where the no dressing intervention group was dependent upon review of medical notes for outcome data]. Where polyurethane film dressings were applied to the skin of subjects undergoing gastrointestinal, urological and gynaecological surgery (position dorsosacral), 10 of 98 developed erythema at the end of surgery with 22 of 103 also showing erythema at the end of surgery if no dressing had been applied (16) . Subjects were monitored for 24 hours with all bar 1 (film dressing group) and 4 (no dressing group) areas of erythema having resolved after 24 hours. Based on these four studies, three patients would need to have a dressing applied to prevent one sacral pressure ulcer.
Comparison between different prophylactic dressings
There were only two comparisons between the effect of different prophylactic dressings upon pressure ulcer prevention (10, 18) . Torra i Bou et al. (18) reported a comparison between the incidence of pressure ulcers at the heel where the heel was protected by a gauze dressing and bandage combination or a hydrocellular dressing. A total of 130 subjects were recruited from six nursing homes and primary health care centres in Spain; however, the number allocated to the intervention (hydrocellular dressing) or control (gauze dressing) arms was not reported. Subjects were followed up for 8 weeks and 44% (control) and 3·3% (intervention) of subjects developed pressure ulcers (severity unreported). The RR of developing pressure ulcers in the gauze and bandage arm was stated to be 13·42 (95% CI 3·31-54·3). In the second comparison between dressings, Weng (11) reported the incidence of nasal pressure damage under face masks where either a transparent film dressing or a hydrocolloid dressing was used to protect the skin. Sixty patients (30 per dressing type) were recruited with no pressure damage around the nose at baseline; the first 30 subjects were allocated the hydrocolloid dressing, of which 12 were reported to have developed category I pressure ulcers under the face mask with the length of follow-up unreported with the skin checked for pressure damage every 30 minutes. The next 30 patients were provided with a film dressing to protect the skin and 16 developed category I pressure ulcers. The incidence of category I pressure ulcers in both dressing groups was similar (X 2 = 1·07, df = 1, P = 0·30). Both studies that compared the effect of different prophylactic dressings upon pressure ulcer incidence were generally of low quality (Table 4 ) with no random allocation of subjects to intervention and control arms, no masking of intervention to staff or data collectors and weak reporting of relevant data; for example, Torra i Bou et al. (18) did not report the number of subjects allocated to the intervention or to the control groups.
Case series reports of prophylactic dressing use
In addition to the ten studies detailed in Table 3 there were ten case series reports that compared the use of dressings to help prevent pressure ulcers with no dressing use (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) and one case series (29) that compared the incidence of nasal pressure ulcers under face masks where a soft silicone foam dressing or a hydrocolloid dressing was used to protect the skin. The characteristics of the case studies are listed in Table 4 and their methodological quality is reported in Table 5 . The case series were typically undertaken in a single intensive care unit (ICU) (seven studies) and explored the prevention of sacral pressure ulcers (seven studies) where the sacrum was protected by a soft silicone foam dressing (six studies). All the case series reported low incidence of new pressure ulcers where dressings were used as part of pressure ulcer prevention. However, the case series studies were generally methodologically weak, often with non-consecutive admission to the study and weak description of the main outcome in terms of failing to define pressure ulcers within the studies. In six case series, no comparison was made between the recorded pressure ulcer incidence and historical data (20, 21, 23, (26) (27) (28) . In two case series, pressure ulcer incidence was compared with historical prevalence proportions (19, 22) and where pressure ulcer incidence was compared with older incidence data, the historical data were presented either as the average number of new ulcers per month (24) or as a percentage with no detail of the number of patients surveyed and the number who developed pressure ulcers (25) . The final case series (29) compared nasal pressure ulcer incidence data gathered over 2006 within one facility, where 47 of 797 (5·9%) patients wearing face mask developed 86 pressure ulcers despite the skin being protected using hydrocolloid dressings below the face mask (51 category I, 33 category II pressure ulcers and 3 category III wounds) primarily on the cheeks (n = 51) and the bridge of the nose (n = 19). Hsu et al. (29) replaced the hydrocolloid dressings because skin peeling and pain on removal were observed on using this dressing (no data presented to support this observation). The skin under the face mask was then protected using a soft silicone foam dressing and the incidence of pressure ulcers due to face masks declined to 0·9% although the number of patients surveyed and the number and severity of encountered pressure ulcers were unreported. None of the case series performed any statistical comparison between the pressure ulcer incidence observed where a dressing was used as part of pressure ulcer prevention and historical pressure ulcer incidences captured in the same facility and unit. 
Discussion
Statement of principal findings
Twenty-one eligible publications were reviewed to establish whether the introduction of a prophylactic dressing applied upon intact skin could help reduce the incidence of pressure ulcers? And if so was there any evidence that different dressings would have a greater or lesser effect on improving pressure ulcer prevention? Three RCTs were identified; of these two (10, 18) were small and failed to describe how random allocation to treatment was achieved. The final RCT (9) was appropriately powered with adequate description of the elements of pressure ulcer prevention that were provided in addition to the placement of soft silicone foam dressing over the sacrum. In the study by Santamaria et al. (9) , the use of the soft silicone foam dressing significantly reduced the incidence of pressure ulcers compared to similar patients who received preventive care but no dressing. While this study indicates that dressings may indeed augment pressure ulcer prevention, it does have limitations that may reduce its external validity to other facilities and patient populations; neither masking of staff to the intervention was possible nor was the reporting of outcomes undertaken with assessors masked to the intervention group. Santamaria et al. (9) recruited trauma patients and acutely ill patients admitted to the ICU through the emergency department of a single hospital among a specific patient population; it is possible that this group of generally immobile people may maintain their dressing in place whereas in a more mobile population, rolling of the edges of the dressing and perhaps dressing removal may occur. The 18 non-RCT studies (7 cohort and 11 case series) reported low pressure ulcer incidence when the dressings were applied to the sacrum, heels, nose and trochanter. However, these studies were methodologically weak and Hawthorne effects cannot be discounted when considering their data.
There were few comparisons between the effects of different dressing materials upon reductions in pressure ulcer incidence. In one small RCT (18), a hydrocellular dressing was compared with a gauze and protective bandage when used to protect the heels of patients receiving care in community settings. The study reported that 3% and 44% of subjects developed heel pressure damage where the heel was protected by the hydrocellular or gauze dressing, respectively, with the numbers of patients in either arm unreported. Weng (11) reported the results of three cohorts of the ICU patients wearing face masks -when no dressing was applied under the mask, 29 of 30 developed pressure damage; with a transparent film between the skin and the mask, 16 of 30 developed damage; whereas a hydrocolloid dressing under the mask reduced the incidence of skin damage to 12 of 30. In the final comparison between different dressings, the incidence of nasal pressure damage among face mask wearers reduced from 5·9% to 0·9% where hydrocolloid or soft silicone foam dressings were positioned under the mask (29) . However, there was no simultaneous comparison of the effect of the hydrocolloid or soft silicone foam dressings, and the changes in pressure ulcer incidence may be influenced by changes in practice or the face mask technology between the time subjects were recruited when hydrocolloid dressings were used and the later use of soft silicone foam.
Implications for health care
The introduction of dressings to increase the protection of vulnerable anatomical sites from pressure ulcers may offer another technique through which the incidence of superficial pressure ulcers may be reduced. Reductions in pressure ulcer incidence may improve both patient and staff satisfaction with health care while also improving the quality of health services through reducing patient harm. Widespread adoption of prophylactic dressings in pressure ulcer prevention may impact upon the costs of pressure area care. Santamaria et al. (30) reported the average marginal cost of using prophylactic dressings to be AUS $36·61, whereas the average cost of pressure ulcer treatment was lower in the intervention group allocated prophylactic dressings (AUS $70·82 for intervention and AUS $144·56 for control group with no prophylactic dressing use). This single economic study suggests that the cost of introducing appropriate use of prophylactic dressings may reduce overall treatment costs given the reductions in pressure ulcer incidence.
Research recommendations
There is limited high-quality evidence linking dressings to improved pressure ulcer prevention. Large-scale studies similar to that of Santamaria et al. (9) will be required to ascertain the most appropriate patient populations, care settings and even perhaps anatomical landmarks where the use of dressings along with other preventive care may reduce pressure ulcer occurrence. At the heel off-loading is recommended to prevent pressure ulceration (1) and use of prophylactic dressings should be compared with heel off-loading before the use of dressings at the heel becomes commonplace. There is also a need for comparative clinical studies between different dressing types to investigate whether in vitro performance differences between dressings, for example, Call et al. (31) translate into differential clinical effects upon pressure ulcer incidence.
Limitations of the review
It may appear strange to use the PRISMA statement to report upon mixed design studies that report the effect of prophylactic dressings upon pressure ulcer incidence with such methodological tools usually seen as appropriate for the synthesis of several RCTs. However, the PRISMA statement (6) comments that the process 'can also be used as a basis for reporting systematic reviews of other types of research, particularly evaluations of interventions'. It may be helpful for future reviews on the effect of pressure ulcer prevention and healing also to follow the PRISMA statement in order to obtain consistently structured reviews across a range of interventions.
The main limitation of the review process was the exclusion of non-English language publications -the search strategy was re-run removing this limitation and two further clinical studies were identified -one in Spanish and the other in Farsi. The paucity of non-English language clinical studies of prophylactic dressings suggests that the conclusions of the review may not have been altered if the two non-English language publications had been included.
There were multiple weaknesses within the retrieved studies, for example, failure to define the length of dressing use, lack of clarity over observed skin changes and were these caused by pressure or could they have resulted from microclimate changes under the dressing or incontinence-associated dermatitis. These failings are common within pressure ulcer prevention studies and not solely related to the topic of prophylactic dressing use.
Conclusions
The single high-quality RCT and the growing number of cohort, weak RCT and case series all suggest that the introduction of a dressing as part of pressure ulcer prevention may help reduce pressure ulcer incidence associated with medical devices and in immobile ICU patients. There is no firm clinical evidence at this time to suggest that one dressing type is more effective than the other dressings.
